scispace - formally typeset
P

Pierre van der Bruggen

Researcher at Université catholique de Louvain

Publications -  187
Citations -  14248

Pierre van der Bruggen is an academic researcher from Université catholique de Louvain. The author has contributed to research in topics: Antigen & Cytotoxic T cell. The author has an hindex of 57, co-authored 187 publications receiving 13331 citations. Previous affiliations of Pierre van der Bruggen include Katholieke Universiteit Leuven & Memorial Sloan Kettering Cancer Center.

Papers
More filters
Journal ArticleDOI

Tumor-antigens recognized by T-lymphocytes

TL;DR: The identification of human tumor rejection antigens opens new possibilities for systematic approaches to the specific immune therapy of cancer.
Journal ArticleDOI

Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy.

TL;DR: The characteristics of tumour antigens that are recognized by spontaneous T cell responses in cancer patients and the paths that led to their identification are described.
Journal ArticleDOI

T cell defined tumor antigens

TL;DR: The priority is now to demonstrate that immunization against some of these antigens is clinically valuable for antitumor therapy, and the first results of clinical pilot studies are now emerging.
Journal ArticleDOI

Human t cell responses against melanoma

TL;DR: In patients who do respond to the vaccine, the antivaccine T cells probably succeed in reversing focally this immunosuppression and trigger a broad activation of other antitumor T cells, which proceed to destroy the tumor.